Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
about
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancerTubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.Consumptive hypothyroidism due to a gastrointestinal stromal tumor expressing type 3 iodothyronine deiodinase.miR-135a promotes gastric cancer progression and resistance to oxaliplatin.Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance
P2860
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
@en
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
@nl
type
label
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
@en
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
@nl
prefLabel
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
@en
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
@nl
P2093
P2860
P356
P1476
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation
@en
P2093
Fan-Biao Kong
Lin-Hai Yan
Qiang Xiao
Wei-Yuan Wei
Xiao-Tong Wang
P2860
P304
P356
10.3748/WJG.V19.I26.4155
P407
P577
2013-07-01T00:00:00Z